{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Relations interprofessionnelles : Questions médicales les plus fréquentes",
"headline": "Relations interprofessionnelles : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Relations interprofessionnelles : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-06",
"dateModified": "2025-04-01",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Relations interprofessionnelles"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Relations interpersonnelles",
"url": "https://questionsmedicales.fr/mesh/D007398",
"about": {
"@type": "MedicalCondition",
"name": "Relations interpersonnelles",
"code": {
"@type": "MedicalCode",
"code": "D007398",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F01.829.401"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Relations médecin-infirmier",
"alternateName": "Physician-Nurse Relations",
"url": "https://questionsmedicales.fr/mesh/D019555",
"about": {
"@type": "MedicalCondition",
"name": "Relations médecin-infirmier",
"code": {
"@type": "MedicalCode",
"code": "D019555",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F01.829.401.205.500"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Relations interprofessionnelles",
"alternateName": "Interprofessional Relations",
"code": {
"@type": "MedicalCode",
"code": "D007400",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Fatemeh Keshmiri",
"url": "https://questionsmedicales.fr/author/Fatemeh%20Keshmiri",
"affiliation": {
"@type": "Organization",
"name": "Associate Professor, Medical Education Department, Education Development Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran."
}
},
{
"@type": "Person",
"name": "Erin Abu-Rish Blakeney",
"url": "https://questionsmedicales.fr/author/Erin%20Abu-Rish%20Blakeney",
"affiliation": {
"@type": "Organization",
"name": "School of Nursing, University of Washington , Seattle , WA , USA."
}
},
{
"@type": "Person",
"name": "Azam Hosseinpour",
"url": "https://questionsmedicales.fr/author/Azam%20Hosseinpour",
"affiliation": {
"@type": "Organization",
"name": "Instructor, Department of Operating Room, School of Allied Medical Sciences, Qom University of Medical Sciences, Qom, Iran."
}
},
{
"@type": "Person",
"name": "Katja Krug",
"url": "https://questionsmedicales.fr/author/Katja%20Krug",
"affiliation": {
"@type": "Organization",
"name": "Department of General Practice and Health Services Research, Heidelberg University Hospital, Im Neuenheimer Feld 130.3, 69120, Heidelberg, Germany. katja.krug@med.uni-heidelberg.de."
}
},
{
"@type": "Person",
"name": "Michel Wensing",
"url": "https://questionsmedicales.fr/author/Michel%20Wensing",
"affiliation": {
"@type": "Organization",
"name": "Department of General Practice and Health Services Research, Heidelberg University Hospital, Im Neuenheimer Feld 130.3, 69120, Heidelberg, Germany."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Cross-sectional quantitative validation of the paediatric Localized Scleroderma Quality of Life Instrument (LoSQI): A disease-specific patient-reported outcome measure.",
"datePublished": "2023-04-12",
"url": "https://questionsmedicales.fr/article/36950970",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/jdv.19059"
}
},
{
"@type": "ScholarlyArticle",
"name": "The Reactivation of Scleroderma After Autologous Fat Grafting.",
"datePublished": "2023-08-15",
"url": "https://questionsmedicales.fr/article/37582285",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/SCS.0000000000009614"
}
},
{
"@type": "ScholarlyArticle",
"name": "Scleroderma autoantibodies in guiding monitoring and treatment decisions.",
"datePublished": "2022-08-29",
"url": "https://questionsmedicales.fr/article/36082759",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/BOR.0000000000000904"
}
},
{
"@type": "ScholarlyArticle",
"name": "Mental health symptoms in scleroderma during COVID-19: a Scleroderma Patient-centred Intervention Network (SPIN) cohort longitudinal study.",
"datePublished": "2023-04-19",
"url": "https://questionsmedicales.fr/article/37083160",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.55563/clinexprheumatol/cca0xv"
}
},
{
"@type": "ScholarlyArticle",
"name": "Juvenile and adult-onset scleroderma: Different clinical phenotypes.",
"datePublished": "2023-03-29",
"url": "https://questionsmedicales.fr/article/37031645",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.semarthrit.2023.152197"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Comportement et mécanismes comportementaux",
"item": "https://questionsmedicales.fr/mesh/D001520"
},
{
"@type": "ListItem",
"position": 3,
"name": "Relations interpersonnelles",
"item": "https://questionsmedicales.fr/mesh/D007398"
},
{
"@type": "ListItem",
"position": 4,
"name": "Relations interprofessionnelles",
"item": "https://questionsmedicales.fr/mesh/D007400"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Relations interprofessionnelles - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Relations interprofessionnelles",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-15",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Relations interprofessionnelles",
"description": "Comment évaluer la communication interprofessionnelle ?\nQuels indicateurs mesurent la collaboration interprofessionnelle ?\nQuels outils facilitent le diagnostic interprofessionnel ?\nComment identifier les barrières à la collaboration ?\nQuel rôle joue la culture organisationnelle dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D007400?mesh_terms=Scleroderma,+Localized&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Relations interprofessionnelles",
"description": "Quels symptômes indiquent une mauvaise communication ?\nComment reconnaître un manque de collaboration ?\nQuels symptômes affectent la dynamique d'équipe ?\nQuels signes montrent une bonne collaboration ?\nComment les symptômes de stress impactent-ils les relations ?",
"url": "https://questionsmedicales.fr/mesh/D007400?mesh_terms=Scleroderma,+Localized&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Relations interprofessionnelles",
"description": "Comment prévenir les conflits interprofessionnels ?\nQuelles stratégies améliorent la prévention des erreurs ?\nComment sensibiliser à l'importance de la collaboration ?\nQuels outils aident à la prévention des erreurs médicales ?\nComment la prévention impacte-t-elle les soins ?",
"url": "https://questionsmedicales.fr/mesh/D007400?mesh_terms=Scleroderma,+Localized&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Relations interprofessionnelles",
"description": "Comment améliorer les traitements par la collaboration ?\nQuels traitements favorisent la communication ?\nComment évaluer l'efficacité des traitements interprofessionnels ?\nQuels traitements sont adaptés aux équipes interprofessionnelles ?\nComment les traitements peuvent-ils être personnalisés ?",
"url": "https://questionsmedicales.fr/mesh/D007400?mesh_terms=Scleroderma,+Localized&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Relations interprofessionnelles",
"description": "Quelles complications résultent d'une mauvaise communication ?\nComment les conflits affectent-ils les résultats des soins ?\nQuelles complications peuvent survenir en cas de mauvaise collaboration ?\nComment évaluer l'impact des complications sur les soins ?\nQuelles sont les conséquences d'une mauvaise dynamique d'équipe ?",
"url": "https://questionsmedicales.fr/mesh/D007400?mesh_terms=Scleroderma,+Localized&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Relations interprofessionnelles",
"description": "Quels facteurs augmentent le risque de conflits ?\nComment le stress influence-t-il les relations interprofessionnelles ?\nQuels facteurs de risque sont liés à la collaboration ?\nComment les différences de statut affectent-elles les relations ?\nQuels facteurs environnementaux influencent la collaboration ?",
"url": "https://questionsmedicales.fr/mesh/D007400?mesh_terms=Scleroderma,+Localized&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment évaluer la communication interprofessionnelle ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des outils d'évaluation comme des questionnaires et des entretiens."
}
},
{
"@type": "Question",
"name": "Quels indicateurs mesurent la collaboration interprofessionnelle ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les indicateurs incluent la satisfaction des patients et l'efficacité des soins."
}
},
{
"@type": "Question",
"name": "Quels outils facilitent le diagnostic interprofessionnel ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les outils incluent des plateformes de partage d'informations et des réunions d'équipe."
}
},
{
"@type": "Question",
"name": "Comment identifier les barrières à la collaboration ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Par des enquêtes et des discussions en groupe pour recueillir des retours d'expérience."
}
},
{
"@type": "Question",
"name": "Quel rôle joue la culture organisationnelle dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une culture ouverte favorise la communication et la collaboration entre les professionnels."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une mauvaise communication ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des erreurs médicales fréquentes et des plaintes des patients peuvent en être des signes."
}
},
{
"@type": "Question",
"name": "Comment reconnaître un manque de collaboration ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des conflits fréquents et un manque de coordination dans les soins sont des indicateurs."
}
},
{
"@type": "Question",
"name": "Quels symptômes affectent la dynamique d'équipe ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress, la frustration et le turnover élevé peuvent affecter la dynamique d'équipe."
}
},
{
"@type": "Question",
"name": "Quels signes montrent une bonne collaboration ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une communication fluide et des résultats positifs pour les patients sont des signes clés."
}
},
{
"@type": "Question",
"name": "Comment les symptômes de stress impactent-ils les relations ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress peut mener à des conflits et à une communication inefficace entre les professionnels."
}
},
{
"@type": "Question",
"name": "Comment prévenir les conflits interprofessionnels ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Par des formations régulières sur la communication et la gestion des conflits."
}
},
{
"@type": "Question",
"name": "Quelles stratégies améliorent la prévention des erreurs ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Mettre en place des protocoles clairs et des revues de cas régulières."
}
},
{
"@type": "Question",
"name": "Comment sensibiliser à l'importance de la collaboration ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Organiser des séminaires et des ateliers sur les bénéfices de la collaboration interprofessionnelle."
}
},
{
"@type": "Question",
"name": "Quels outils aident à la prévention des erreurs médicales ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les check-lists et les systèmes de double vérification sont des outils efficaces."
}
},
{
"@type": "Question",
"name": "Comment la prévention impacte-t-elle les soins ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une bonne prévention réduit les erreurs et améliore la satisfaction des patients."
}
},
{
"@type": "Question",
"name": "Comment améliorer les traitements par la collaboration ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "En intégrant des équipes multidisciplinaires pour une approche globale des soins."
}
},
{
"@type": "Question",
"name": "Quels traitements favorisent la communication ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des formations en communication et des ateliers de team-building sont bénéfiques."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'efficacité des traitements interprofessionnels ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Par des études de cas et des analyses de résultats cliniques post-traitement."
}
},
{
"@type": "Question",
"name": "Quels traitements sont adaptés aux équipes interprofessionnelles ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements complexes comme la gestion de la douleur nécessitent une approche collaborative."
}
},
{
"@type": "Question",
"name": "Comment les traitements peuvent-ils être personnalisés ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "En tenant compte des compétences et des expertises de chaque professionnel de santé."
}
},
{
"@type": "Question",
"name": "Quelles complications résultent d'une mauvaise communication ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des erreurs de traitement et des retards dans les soins peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment les conflits affectent-ils les résultats des soins ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les conflits peuvent mener à des soins fragmentés et à une insatisfaction des patients."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir en cas de mauvaise collaboration ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications médicales et des réadmissions fréquentes peuvent en résulter."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'impact des complications sur les soins ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Par des analyses de données sur les résultats cliniques et la satisfaction des patients."
}
},
{
"@type": "Question",
"name": "Quelles sont les conséquences d'une mauvaise dynamique d'équipe ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une mauvaise dynamique peut entraîner un turnover élevé et une baisse de la qualité des soins."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de conflits ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des différences culturelles et des styles de communication variés peuvent augmenter les conflits."
}
},
{
"@type": "Question",
"name": "Comment le stress influence-t-il les relations interprofessionnelles ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress peut réduire la communication et augmenter les tensions entre les professionnels."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque sont liés à la collaboration ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un manque de formation et des horaires de travail chargés peuvent nuire à la collaboration."
}
},
{
"@type": "Question",
"name": "Comment les différences de statut affectent-elles les relations ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les différences de statut peuvent créer des déséquilibres et des tensions dans l'équipe."
}
},
{
"@type": "Question",
"name": "Quels facteurs environnementaux influencent la collaboration ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un environnement de travail positif et des ressources adéquates favorisent la collaboration."
}
}
]
}
]
}
The Localized Scleroderma Quality of Life Instrument (LoSQI) is a disease-specific patient-reported outcome (PRO) measure designed for children and adolescents with localized scleroderma (LS; morphea)...
The purpose of this study was to evaluate the psychometric properties of the LoSQI in a clinical setting....
Cross-sectional data from four specialized clinics in the US and Canada were included in the analysis. Evaluation included reliability of scores, internal structure of the survey, evidence of converge...
One hundred and ten patients with LS (age: 8-20 years) completed the LoSQI. Both exploratory and confirmatory factor analysis supported the use of two sub-scores: Pain and Physical Functioning, and Bo...
This study did not evaluate longitudinal validity or responsiveness of scores....
Results from a representative sample of children and adolescents with LS continue to support the validity of the LoSQI when used in a clinical setting. Future work to evaluate the responsiveness is on...
Patients with localized scleroderma (LS) often have to seek plastic surgery to improve facial esthetic impairment....
The authors reported a case of the reactivation of LS after autologous fat grafting (AFG)....
A man presented with facial atrophy and skin fibrosis on the cheek with a history of LS. The disease had remained stable for 9 years and he was suggested to stop oral medication. With irreversible est...
Six months after the last AFG, the patient found new lesions occur on the lateral forehead. The patient was later diagnosed with reactivation of LS....
The understanding of the surgical risk and perioperative management for patients with LS needs more research....
One of the key clinical challenges of systemic sclerosis (SSc) is diversity in clinical presentation, organ involvement and disease progression. Antinuclear autoantibodies (ANA) are central to the dia...
There has been further development in delineating clinical patterns in ANA, genetic susceptibility and antigen triggers predisposing to ANA subtypes. Sub-group analysis of recent clinical trials shows...
ANA subtyping is likely to be firmly embedded into future classification systems. Beyond informing current management and monitoring of scleroderma patients, ANA subsets have implication on future res...
People with systemic sclerosis (SSc) are vulnerable in COVID-19 and face challenges related to shifting COVID-19 risk and protective restrictions. We evaluated mental health symptom trajectories in pe...
The longitudinal Scleroderma Patient-centred Intervention Network (SPIN) COVID-19 cohort was launched in April 2020 and included participants from the ongoing SPIN Cohort and external enrolees. Analys...
Anxiety symptoms increased in early 2020 but returned to pre-COVID-19 levels by mid-2020 and remained stable through March 2022. Depression symptoms did not initially change but were slightly lower by...
People with SSc continue to face COVID-19 challenges related to ongoing risk, the opening of societies, and removal of protective restrictions. People with SSc, in aggregate, appear to be weathering t...
Systemic sclerosis (SSc) represents extremely rare disease with majority of data coming from adults. Studies comparing juvenile- (jSSc) and adult-onset (aSSc) patients are limited. We aimed to compare...
A retrospective study among pediatric and adult Scl patients has been performed. Demographic characteristics, clinical features, autoantibody profiles, and treatment data were retrieved from the datab...
A total of 158 adults and 58 juvenile Scl patients were identified. The mean age at the disease onset was 37±14.7 vs. 8.8 ± 4.1 years, mean age at diagnosis 42±15.2 vs. 10.4 ± 3.8 years and mean follo...
Juvenile and adult-onset Scl represent rarely seen conditions with different clinical phenotypes. Pediatric patients with LS are more commonly seen by pediatric rheumatologists, in contrary to adults....
We investigated the ability of a panel of immune-related cytokines and chemokines to predict the disease activity state in localized scleroderma (LS) subjects followed longitudinally. A total of 194 s...
Systemic sclerosis (SSc) is characterized by the presence of SSc-specific or SSc-associated antibodies (SSc-Abs): anti-topoisomerase I (ATA), anti-centromere (ACA), anti-RNA polymerase III (ARA), anti...
Erectile dysfunction (ED) has been reported among patients with systemic sclerosis (SSc) and primarily limited cutaneous SSc in Caucasians. While there is no data on ED among Thais in whom the diffuse...
We aimed to estimate the prevalence of ED among Thais with SSc, evaluate its severity, and determine the associated factors....
We did a cross-sectional study among adult Thai male SSc patients. All eligible patients: a) completed the IIEF-15 questionnaire by themselves; b) underwent a genital examination by an experienced uro...
A total of 60 male SSc patients were included. The respective mean age and median disease duration was 54.8±7.2 years and 3.1 years (IQR 1.2-7.2). The definition of ED was fulfilled in 53 cases for a ...
ED is a common problem in men with SSc and is mainly categorized as severe. The severity of SSc might increase the risk of developing ED. We found phimosis was a common genital abnormality co-occurrin...
Scleroderma renal crisis (SRC) is a life-threatening complication of systemic sclerosis (SSc) with a mortality of 20% at 6 months. Once the leading cause of mortality in scleroderma (SSc), it remains ...
Morphea presenting clinically with nodular or keloidal skin changes is extremely rare. Nodular scleroderma or keloidal morphea presenting in a linear distribution is even more uncommon. We present an ...